Details for Patent: 10,512,657
✉ Email this page to a colleague
Which drugs does patent 10,512,657 protect, and when does it expire?
Patent 10,512,657 protects LIVMARLI and is included in two NDAs.
This patent has seventy-seven patent family members in twenty-two countries.
Drugs Protected by US Patent 10,512,657
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mirum | LIVMARLI | maralixibat chloride | SOLUTION;ORAL | 214662-001 | Sep 29, 2021 | RX | Yes | Yes | 10,512,657 | ⤷ Start Trial | TREATMENT OF CHOLESTATIC PRURITUS IN PATIENTS WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTATIS (PFIC) | ⤷ Start Trial | ||||
| Mirum | LIVMARLI | maralixibat chloride | SOLUTION;ORAL | 214662-002 | Jul 24, 2024 | RX | Yes | Yes | 10,512,657 | ⤷ Start Trial | TREATMENT OF CHOLESTATIC PRURITUS IN PATIENTS 12 MONTHS OF AGE AND OLDER WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS (PFIC) | ⤷ Start Trial | ||||
| Mirum | LIVMARLI | maralixibat chloride | TABLET;ORAL | 219485-001 | Apr 10, 2025 | RX | Yes | No | 10,512,657 | ⤷ Start Trial | TREATMENT OF CHOLESTATIC PRURITUS IN PATIENTS 12 MONTHS OF AGE AND OLDER WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS (PFIC) WHO WEIGH 25 KILOGRAMS AND ABOVE | ⤷ Start Trial | ||||
| Mirum | LIVMARLI | maralixibat chloride | TABLET;ORAL | 219485-002 | Apr 10, 2025 | RX | Yes | No | 10,512,657 | ⤷ Start Trial | TREATMENT OF CHOLESTATIC PRURITUS IN PATIENTS 12 MONTHS OF AGE AND OLDER WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS (PFIC) WHO WEIGH 25 KILOGRAMS AND ABOVE | ⤷ Start Trial | ||||
| Mirum | LIVMARLI | maralixibat chloride | TABLET;ORAL | 219485-003 | Apr 10, 2025 | RX | Yes | No | 10,512,657 | ⤷ Start Trial | TREATMENT OF CHOLESTATIC PRURITUS IN PATIENTS 12 MONTHS OF AGE AND OLDER WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS (PFIC) WHO WEIGH 25 KILOGRAMS AND ABOVE | ⤷ Start Trial | ||||
| Mirum | LIVMARLI | maralixibat chloride | TABLET;ORAL | 219485-004 | Apr 10, 2025 | RX | Yes | Yes | 10,512,657 | ⤷ Start Trial | TREATMENT OF CHOLESTATIC PRURITUS IN PATIENTS 12 MONTHS OF AGE AND OLDER WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS (PFIC) WHO WEIGH 25 KILOGRAMS AND ABOVE | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,512,657
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2771003 | ⤷ Start Trial | 2023C/521 | Belgium | ⤷ Start Trial |
| European Patent Office | 2771003 | ⤷ Start Trial | 301234 | Netherlands | ⤷ Start Trial |
| European Patent Office | 2771003 | ⤷ Start Trial | CA 2023 00017 | Denmark | ⤷ Start Trial |
| European Patent Office | 2771003 | ⤷ Start Trial | 122023000029 | Germany | ⤷ Start Trial |
| European Patent Office | 2771003 | ⤷ Start Trial | 21/2023 | Austria | ⤷ Start Trial |
| European Patent Office | 2771003 | ⤷ Start Trial | CR 2023 00017 | Denmark | ⤷ Start Trial |
| European Patent Office | 2771003 | ⤷ Start Trial | 2390017-8 | Sweden | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
